Search Results 211-220 of 1789 for 必应搜索引擎优化咨询邮箱：lgooxc@hotmail.com

1. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. Admissions - Center for Clinical and Translational Science

   This program is officially known as the Medical Scientist Training Program and is jointly offered by Mayo Medical School and Mayo Graduate School. For ...

3. A Blanket Protocol to Study Oral Regorafenib in Patients with Selected Sarcoma Subtypes - Mayo Clinic

   Regorafenib might or might not slow down the growth of your tumor, or shrink your tumor. Regorafenib is approved in the United States to treat colon cancer and ...

4. Faculty and staff - Alzheimer's Disease Research Center - Mayo Clinic Research

   A multidisciplinary faculty guides research in the Mayo Clinic Alzheimer's Disease Research Center.

5. Contact us - Mayo Clinic

   For information about making a gift, call 855-852-8129. To request a medical appointment, see Appointments at Mayo Clinic. Email. development@mayo.edu. Mail.

6. A Study of Speech Changes as Predictors of Migraine Attack Onset - Mayo Clinic

   The purpose of this study is to predict migraine headache onset from changes in speech in people who have a history of migraines. Participation eligibility.

7. First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects with Acute Myelogenous Leukemia and Selected B-cell Cancers - Mayo Clinic

   About this study. The purpose of this study is to assess the safety and tolerability of BMS-936564 (MDX-1338) in relapsed Acute myelogenous leukemia (AML) ...

8. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

   Pazopanib hydrochloride may also stop the growth of kidney cancer by blocking blood flow to the tumor. Participation eligibility. Participant eligibility ...

9. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

   This is a multi-center, open label, single arm phase II study evaluating BGJ398 anti-tumor activity in advanced or metastatic cholangiocarcinoma patients with ...

10. A Study to Evaluate Pembrolizumab Combined with Intensive Chemotherapy to Treat Patients with Acute Myeloid Leukemia - Mayo Clinic

    Drugs used in chemotherapy, such as cytarabine, idarubicin, and daunorubicin, work in different ways to stop the growth of cancer cells, either by killing the ...